RBR-5smtym尚未招募未知
Polysomnographic evaluation of adult patients with Obstructive Sleep Apnea (OSAS) undergoing Orthopedic Maxillary Expansion
niversidade Estadual de Campinas0 个研究点开始时间: 2020年8月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 21Y 至 65Y（—）
入选标准
- •adults, 21 to 65 years old, diagnosed with OSAS by polysomnography; intolerance to continuous positive airway pressure (CPAP); with maxillary atresia; Mallampati 3 or 4; without palatine or lingual tonsillar hypertrophy
排除标准
- •Patients with missing more than one upper molar, patients with dentures or partial or total dental implants; who have periodontal disease with alveolar bone loss; caries or extensive coronary destruction in posterior upper teeth; who do not agree with the informed consent form
研究者
相似试验
尚未招募
不适用
The evaluation of sleep disorders in patients with interstitial lung diseaseinterstitial lung diseaseJPRN-UMIN000029472Toranomon Hospital125
尚未招募
不适用
Evaluation of Sleep-e: an online treatment program for insomniaMental Health - Other mental health disordersInsomniaACTRN12613001306707ational eTherapy Centre, Swinburne University of Technology70
已完成
不适用
Evaluation of polysomnography data in the treatment of sleep respiratory disorders with intraoral language stabilization device: randomized clinical trialsleep apnearespiratory diseasesG47.3RBR-5dy35nniversidade Federal de São Paulo
尚未招募
不适用
Study in children with Obstructive Sleep Apnea, after surgery, treated with a dental appliance or speech therapySleep Apnea, ObstructivePalatal Expansion TechniqueMyofunctional TherapyTonsillectomyActivator AppliancesC08.618.085.852.850E06.658.578.458E02.760.169.063.500.727.442E04.580.848E06.658.453.560.100RBR-222dr8Faculdade de Ciência Médicas - Unicamp
进行中（未招募）
不适用
A 28-Day, Polysomnographic and Subjective Assessment of Vestipitant (15mg/day) for the Treatment of Primary Insomnia in Adult Outpatients.Primary Insomnia in Adult OutpatientsMedDRA version: 9.1Level: LLTClassification code 10036701Term: Primary insomniaEUCTR2008-006345-72-DEGlaxoSmithKline Research & Development Ltd152